Share this Job

Assistant Scientist 1

Req ID:  41408
Location: 

Tranent, ELN, GB, EH33 2NE

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

 

 

The above vacancy now exists in OA01 (In Vitro Sciences).

At present we are looking for an Assistant Scientist to join the In Vitro Investigative Toxicology team located at Elvingston, East Lothian.  The fields that we typically work in include in vitro inhalation toxicology and drug membrane permeability.  The testing that we perform is frequently bespoke and one-off, researched and devised in collaboration with our clients on a case-by-case basis to solve their particular scientific questions.  Our skills lie in being able to combine a broad range of toxicological, physiological and other endpoints with numerous in vitro tissue and cell culture models to make a custom test design when existing and established models do not meet our client’s needs. 

The successful applicant will participate in literature review, design, performing and reporting a wide range of in vitro studies.  Duties will also include data checking, reagent preparation and cell culture.  The team works collaboratively with many other groups both internally and outside Charles River, so excellent communication and networking skills are required.  You should poses an Honours degree or equivalent in a life science subject.  Experience of in vitro toxicology techniques (e.g. working with 3D cell models and cell culture) and working in a GLP environment would be an advantage although not essential since training will be provided.

Salary for this position will be Scale 4 dependent upon qualifications and/or relevant experience.

All internal applicants should apply through the careers page in Talent Hub.

The closing date for this vacancy is 31 January 2019.

 

About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

 

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

 

With over 13,000 employees within 80 facilities in 23 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges.  Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.

 

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 80% of the drugs approved by the FDA in 2017.

 

For more information, please visit www.criver.com.